SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(Montgomery P) "

Search: WFRF:(Montgomery P)

  • Result 11-20 of 302
Sort/group result
   
EnumerationReferenceCoverFind
11.
  • Abazov, V. M., et al. (author)
  • Measurement of the W Boson Mass with the D0 Detector
  • 2012
  • In: Physical Review Letters. - 0031-9007 .- 1079-7114. ; 108:15, s. 151804-
  • Journal article (peer-reviewed)abstract
    • We present a measurement of the W boson mass using data corresponding to 4: 3 fb(-1) of integrated luminosity collected with the D0 detector during Run II at the Fermilab Tevatron p (p) over tilde collider. With a sample of 1 677 394 W -> e nu candidate events, we measure M-W = 80.367 +/- 0.026 GeV. This result is combined with an earlier D0 result determined using an independent Run II data sample, corresponding to 1 fb(-1) of integrated luminosity, to yield MW 80.375 +/- 0.023 GeV.
  •  
12.
  • Abazov, M, et al. (author)
  • A novel method for modeling the recoil in W boson events at hadron colliders
  • 2009
  • In: Nuclear Instruments and Methods in Physics Research Section A. - : Elsevier BV. - 0168-9002 .- 1872-9576. ; 609:2-3, s. 250-262
  • Journal article (peer-reviewed)abstract
    • We present a new method for modeling the hadronic recoil in W -> lv events produced at hadron colliders. The recoil is chosen from a library of recoils in Z -> ll data events and overlaid on a simulated W -> lv event. Implementation of this method requires that the data recoil library describe the proper-ties of the measured recoil as a function of the true, rather than the measured, transverse momentum of the boson. We address this issue using a multidimensional Bayesian unfolding technique. We estimate the statistical and systematic uncertainties from this method for the W boson mass and width measurements assuming 1 fb(-1) of data from the Fermilab Tevatron. The uncertainties are found to be small and comparable to those of a more traditional parameterized recoil model. For the highprecision measurements that will be possible with data from Run 11 of the Fermilab Tevatron and from the CERN LHC, the method presented in this paper may be advantageous, since it does not require an understanding of the measured recoil from first principles.
  •  
13.
  •  
14.
  • Abazov, V. M., et al. (author)
  • Measurement of the W boson mass with the D0 detector
  • 2014
  • In: Physical Review D. - 1550-7998 .- 1550-2368. ; 89:1, s. 012005-
  • Journal article (peer-reviewed)abstract
    • We give a detailed description of the measurement of the W boson mass, M-W, performed on an integrated luminosity of 4.3 fb(-1), which is based on similar techniques as used for our previous measurement done on an independent data set of 1 fb(-1) of data. The data were collected using the D0 detector at the Fermilab Tevatron Collider. This data set yields 1.68 x 10(6) W -> ev candidate events. We measure the mass using the transverse mass, electron transverse momentum, and missing transverse energy distributions. The M-W measurements using the transverse mass and the electron transverse momentum distributions are the most precise of these three and are combined to give M-W 80.367 +/- 0.013 (stat) +/- 0.022(syst) GeV = 80: 367 +/- 0.026 GeV. When combined with our earlier measurement on 1 fb(-1) of data, we obtain M-W = 80.375 +/- 0.023 GeV.
  •  
15.
  • Mullins, N., et al. (author)
  • Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology
  • 2021
  • In: Nature Genetics. - : Springer Science and Business Media LLC. - 1061-4036 .- 1546-1718. ; 53, s. 817-829
  • Journal article (peer-reviewed)abstract
    • Bipolar disorder is a heritable mental illness with complex etiology. We performed a genome-wide association study of 41,917 bipolar disorder cases and 371,549 controls of European ancestry, which identified 64 associated genomic loci. Bipolar disorder risk alleles were enriched in genes in synaptic signaling pathways and brain-expressed genes, particularly those with high specificity of expression in neurons of the prefrontal cortex and hippocampus. Significant signal enrichment was found in genes encoding targets of antipsychotics, calcium channel blockers, antiepileptics and anesthetics. Integrating expression quantitative trait locus data implicated 15 genes robustly linked to bipolar disorder via gene expression, encoding druggable targets such as HTR6, MCHR1, DCLK3 and FURIN. Analyses of bipolar disorder subtypes indicated high but imperfect genetic correlation between bipolar disorder type I and II and identified additional associated loci. Together, these results advance our understanding of the biological etiology of bipolar disorder, identify novel therapeutic leads and prioritize genes for functional follow-up studies. Genome-wide association analyses of 41,917 bipolar disorder cases and 371,549 controls of European ancestry provide new insights into the etiology of this disorder and identify novel therapeutic leads and potential opportunities for drug repurposing.
  •  
16.
  • Munn-Chernoff, M. A., et al. (author)
  • Shared genetic risk between eating disorder- and substance-use-related phenotypes: Evidence from genome-wide association studies
  • 2021
  • In: Addiction Biology. - : Wiley. - 1355-6215 .- 1369-1600. ; 26:1
  • Journal article (peer-reviewed)abstract
    • Eating disorders and substance use disorders frequently co-occur. Twin studies reveal shared genetic variance between liabilities to eating disorders and substance use, with the strongest associations between symptoms of bulimia nervosa and problem alcohol use (genetic correlation [r(g)], twin-based = 0.23-0.53). We estimated the genetic correlation between eating disorder and substance use and disorder phenotypes using data from genome-wide association studies (GWAS). Four eating disorder phenotypes (anorexia nervosa [AN], AN with binge eating, AN without binge eating, and a bulimia nervosa factor score), and eight substance-use-related phenotypes (drinks per week, alcohol use disorder [AUD], smoking initiation, current smoking, cigarettes per day, nicotine dependence, cannabis initiation, and cannabis use disorder) from eight studies were included. Significant genetic correlations were adjusted for variants associated with major depressive disorder and schizophrenia. Total study sample sizes per phenotype ranged from similar to 2400 to similar to 537 000 individuals. We used linkage disequilibrium score regression to calculate single nucleotide polymorphism-based genetic correlations between eating disorder- and substance-use-related phenotypes. Significant positive genetic associations emerged between AUD and AN (r(g) = 0.18; false discovery rate q = 0.0006), cannabis initiation and AN (r(g) = 0.23; q < 0.0001), and cannabis initiation and AN with binge eating (r(g) = 0.27; q = 0.0016). Conversely, significant negative genetic correlations were observed between three nondiagnostic smoking phenotypes (smoking initiation, current smoking, and cigarettes per day) and AN without binge eating (r(gs) = -0.19 to -0.23; qs < 0.04). The genetic correlation between AUD and AN was no longer significant after co-varying for major depressive disorder loci. The patterns of association between eating disorder- and substance-use-related phenotypes highlights the potentially complex and substance-specific relationships among these behaviors.
  •  
17.
  • Justice, A. E., et al. (author)
  • Genome-wide meta-analysis of 241,258 adults accounting for smoking behaviour identifies novel loci for obesity traits
  • 2017
  • In: Nature Communications. - : Springer Science and Business Media LLC. - 2041-1723. ; 8
  • Journal article (peer-reviewed)abstract
    • Few genome-wide association studies (GWAS) account for environmental exposures, like smoking, potentially impacting the overall trait variance when investigating the genetic contribution to obesity-related traits. Here, we use GWAS data from 51,080 current smokers and 190,178 nonsmokers (87% European descent) to identify loci influencing BMI and central adiposity, measured as waist circumference and waist-to-hip ratio both adjusted for BMI. We identify 23 novel genetic loci, and 9 loci with convincing evidence of gene-smoking interaction (GxSMK) on obesity-related traits. We show consistent direction of effect for all identified loci and significance for 18 novel and for 5 interaction loci in an independent study sample. These loci highlight novel biological functions, including response to oxidative stress, addictive behaviour, and regulatory functions emphasizing the importance of accounting for environment in genetic analyses. Our results suggest that tobacco smoking may alter the genetic susceptibility to overall adiposity and body fat distribution.
  •  
18.
  • Marconi, A., et al. (author)
  • ANDES, the high resolution spectrograph for the ELT : science case, baseline design and path to construction
  • 2022
  • In: GROUND-BASED AND AIRBORNE INSTRUMENTATION FOR ASTRONOMY IX. - : SPIE - International Society for Optical Engineering. - 9781510653504 - 9781510653498
  • Conference paper (peer-reviewed)abstract
    • The first generation of ELT instruments includes an optical-infrared high resolution spectrograph, indicated as ELT-HIRES and recently christened ANDES (ArmazoNes high Dispersion Echelle Spectrograph). ANDES consists of three fibre-fed spectrographs (UBV, RIZ, YJH) providing a spectral resolution of similar to 100,000 with a minimum simultaneous wavelength coverage of 0.4-1.8 mu m with the goal of extending it to 0.35-2.4 mu m with the addition of a K band spectrograph. It operates both in seeing- and diffraction-limited conditions and the fibre-feeding allows several, interchangeable observing modes including a single conjugated adaptive optics module and a small diffraction-limited integral field unit in the NIR. Its modularity will ensure that ANDES can be placed entirely on the ELT Nasmyth platform, if enough mass and volume is available, or partly in the Coude room. ANDES has a wide range of groundbreaking science cases spanning nearly all areas of research in astrophysics and even fundamental physics. Among the top science cases there are the detection of biosignatures from exoplanet atmospheres, finding the fingerprints of the first generation of stars, tests on the stability of Nature's fundamental couplings, and the direct detection of the cosmic acceleration. The ANDES project is carried forward by a large international consortium, composed of 35 Institutes from 13 countries, forming a team of more than 200 scientists and engineers which represent the majority of the scientific and technical expertise in the field among ESO member states.
  •  
19.
  • Bryois, J., et al. (author)
  • Genetic identification of cell types underlying brain complex traits yields insights into the etiology of Parkinson’s disease
  • 2020
  • In: Nature Genetics. - : Springer Science and Business Media LLC. - 1061-4036 .- 1546-1718. ; 52:5, s. 482-493
  • Journal article (peer-reviewed)abstract
    • Genome-wide association studies have discovered hundreds of loci associated with complex brain disorders, but it remains unclear in which cell types these loci are active. Here we integrate genome-wide association study results with single-cell transcriptomic data from the entire mouse nervous system to systematically identify cell types underlying brain complex traits. We show that psychiatric disorders are predominantly associated with projecting excitatory and inhibitory neurons. Neurological diseases were associated with different cell types, which is consistent with other lines of evidence. Notably, Parkinson’s disease was genetically associated not only with cholinergic and monoaminergic neurons (which include dopaminergic neurons) but also with enteric neurons and oligodendrocytes. Using post-mortem brain transcriptomic data, we confirmed alterations in these cells, even at the earliest stages of disease progression. Our study provides an important framework for understanding the cellular basis of complex brain maladies, and reveals an unexpected role of oligodendrocytes in Parkinson’s disease. © 2020, The Author(s), under exclusive licence to Springer Nature America, Inc.
  •  
20.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 11-20 of 302
Type of publication
journal article (260)
conference paper (32)
research review (7)
other publication (1)
doctoral thesis (1)
book chapter (1)
show more...
show less...
Type of content
peer-reviewed (256)
other academic/artistic (45)
pop. science, debate, etc. (1)
Author/Editor
Montgomery, GW (89)
Martin, NG (82)
Esko, T (50)
Metspalu, A (49)
Willemsen, G (48)
Boomsma, DI (48)
show more...
Hottenga, JJ (47)
Stefansson, K (46)
Montgomery, Grant W. (46)
Hayward, C. (45)
Medland, SE (44)
Teumer, A (42)
Martin, Nicholas G. (39)
Uitterlinden, AG (38)
Cichon, S (37)
Ripke, S (36)
Kutalik, Z. (34)
Breen, G (33)
Muller-Myhsok, B (33)
Rietschel, M (33)
Pedersen, NL (32)
Penninx, BWJH (32)
Mattheisen, M (30)
Nauck, M (30)
Nothen, MM (30)
Lucae, S (30)
Gordon, SD (30)
Davies, G (29)
Kaprio, J (29)
Yang, J. (29)
Milaneschi, Y (29)
Palotie, A (29)
Herms, S. (29)
Volzke, H (28)
Sullivan, PF (26)
Degenhardt, F (26)
van Duijn, CM (25)
Craddock, N (25)
Rujescu, D (25)
Magnusson, PKE (25)
De Geus, EJC (25)
Gudnason, V (25)
Smoller, JW (25)
Deary, IJ (25)
Wray, NR (25)
Boomsma, Dorret I. (25)
Gieger, C (25)
Strohmaier, J (25)
Frank, J (25)
Gill, M. (25)
show less...
University
Karolinska Institutet (221)
Uppsala University (89)
Lund University (67)
University of Gothenburg (46)
Umeå University (34)
Örebro University (32)
show more...
Jönköping University (13)
Stockholm University (12)
University of Skövde (10)
Högskolan Dalarna (8)
Stockholm School of Economics (7)
Linköping University (6)
Royal Institute of Technology (5)
Luleå University of Technology (2)
University of Borås (2)
Halmstad University (1)
Chalmers University of Technology (1)
Karlstad University (1)
Swedish University of Agricultural Sciences (1)
show less...
Language
English (302)
Research subject (UKÄ/SCB)
Medical and Health Sciences (158)
Natural sciences (34)
Social Sciences (5)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view